Source: Medicines & Healthcare Products Regulatory Agency (GB) Revision Year: 2018 Publisher: Focus Pharmaceuticals Ltd, Capital House, 85 King William Street, London EC4N 7BL, United Kingdom
Mupirocin 2% w/w Ointment.
| Pharmaceutical Form |
|---|
|
Ointment in a white, translucent, water-soluble, polyethylene glycol base. |
Each gram of ointment contains 20 mg mupirocin (2% w/w mupirocin).
For the full list of excipients, see Section 6.1.
| Active Ingredient | Description | |
|---|---|---|
| Mupirocin |
Mupirocin is a novel antibiotic produced through fermentation by Pseudomonas fluorescens. Mupirocin inhibits isoleucyl transfer-RNA synthetase, thereby arresting bacterial protein synthesis. Mupirocin has bacteriostatic properties at minimum inhibitory concentrations and bactericidal properties at the higher concentrations reached when applied locally. |
| List of Excipients |
|---|
|
Macrogol 400 |
15g aluminium tube internally coated with an epoxy non-toxic resin closed with polyethylene screw caps.
Focus Pharmaceuticals Ltd, Capital House, 85 King William Street, London EC4N 7BL, United Kingdom
PL 20046/0071
16/12/2011
| Drug | Countries | |
|---|---|---|
| MUPIROCIN | Austria, Nigeria |
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
